Galveston National Laboratory

Dr. Tom Geisbert and Dr. Robert Cross are co-PIs on a new project agreement awarded by the US Department of Defense and BARDA for vaccine development targeting pathogens of concern to U.S. Military.

A new study published in Proceedings of the National Academy of Sciences details the development of a new vaccine to combat Nipah virus.

In this article by STAT's Andrew Joseph, the author details the challenges of creating a new vaccine for COVID-19, explains how the process is being fast-tracked, and discusses the gambles being taken on manufacturing in advance of approvals in hopes of positive clinical trial results. UTMB's Dr. Jim Le Duc, Director of the Galveston National Lab, is featured as one of the experts in the story. Click on the photo for the full story.